Articles in E-pub version are posted online ahead of regular printed publication.
-
Original Articles
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- DOI: 10.3350/cmh.2023.0089 [Epub ahead of print]
-
Editorials
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
- Do Young Kim
- DOI: 10.3350/cmh.2023.0107 [Epub ahead of print]
-
Reviews
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Japanese perspective
- Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
- DOI: 10.3350/cmh.2023.0102 [Epub ahead of print]
-
Editorials
Challenges in Translating Clinical Practice Guidelines into Real-Life Practice for the management of hepatocellular carcinoma in Taiwan
- San-Chi Chen
- DOI: 10.3350/cmh.2023.0101 [Epub ahead of print]
-
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
- Shen-Yung Wang
- DOI: 10.3350/cmh.2023.0082 [Epub ahead of print]
-
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
- Philipp Kasper, Münevver Demir, Hans-Michael Steffen
- DOI: 10.3350/cmh.2023.0059 [Epub ahead of print]
-
Is liver biopsy mandatory to identify immune-tolerant phase of chronic hepatitis B?
- Joo Hyun Oh, Dong Hyun Sinn
- DOI: 10.3350/cmh.2023.0054 [Epub ahead of print]
-
Reviews
Acute -on- Chronic liver failure – Terminology, Mechanisms and Management
- Vinay Kumar BR, Shiv Kumar Sarin
- DOI: 10.3350/cmh.2022.0103 [Epub ahead of print]
-
Editorials
Management of Hepatocellular Carcinoma in China:
Seeking Common Grounds While Reserving Differences
- Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
- DOI: 10.3350/cmh.2023.0106 [Epub ahead of print]
-
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
- Ji-Won Park, Ki Tae Suk
- DOI: 10.3350/cmh.2023.0085 [Epub ahead of print]
-
What should be done to reduce the discrepancy between guidelines and real-life practice for HCC in Korea?
- Min Kyung Park, Yoon Jun Kim
- DOI: 10.3350/cmh.2023.0080 [Epub ahead of print]
-
The clinical management of HCC in China: progresses and challenges
- Shan Shan, Jidong Jia
- DOI: 10.3350/cmh.2023.0077 [Epub ahead of print]
-
The current trends in the health burden of primary liver cancer across the globe
- Peter Konyn, Aijaz Ahmed, Donghee Kim
- DOI: 10.3350/cmh.2023.0092 [Epub ahead of print]
-
Changing the nomenclature from NAFLD to MAFLD is more than a change in terminology
- Eileen Laurel Yoon, Dae Won Jun
- DOI: 10.3350/cmh.2023.0086 [Epub ahead of print]
-
Editorial: HCC surveillance in non-alcoholic fatty liver disease – who and how?
- Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
- DOI: 10.3350/cmh.2023.0069 [Epub ahead of print]
-
Implications of comorbidities in nonalcoholic fatty liver disease
- Sherlot Juan Song, Vincent Wai-Sun Wong
- DOI: 10.3350/cmh.2023.0066 [Epub ahead of print]
-
Reviews
Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm
- Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
- DOI: 10.3350/cmh.2022.0420 [Epub ahead of print]
-
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: Asian perspective comparison
- Yuri Cho, Bo Hyun Kim, Joong-Won Park
- DOI: 10.3350/cmh.2023.0099 [Epub ahead of print]
-
Editorials
The prime time for management of hepatocellular carcinoma in Hong Kong
- Landon L. Chan, Stephen L. Chan
- DOI: 10.3350/cmh.2023.0094 [Epub ahead of print]
-
Non-obese or lean nonalcoholic fatty liver disease matters but is it preventable or inevitable in light of its risk factors?
- Heejoon Jang, Won Kim
- DOI: 10.3350/cmh.2023.0088 [Epub ahead of print]
-
The Imitator of Immune-Tolerant Phase in Chronic Hepatitis B: A Killer in Disguise
- Moon Haeng Hur, Jeong-Hoon Lee
- DOI: 10.3350/cmh.2023.0079 [Epub ahead of print]
-
The latest global burden of liver cancer: A past and present threat
- Joo Hyun Oh, Dae Won Jun
- DOI: 10.3350/cmh.2023.0070 [Epub ahead of print]
-
Lean vs. obese NAFLD, two phenotypes of NAFLD: look the same but different or vice versa?
- Ho Soo Chun, Minjong Lee
- DOI: 10.3350/cmh.2023.0061 [Epub ahead of print]
-
Reviews
Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy
- Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
- DOI: 10.3350/cmh.2022.0434 [Epub ahead of print]
-
Original Articles
Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
- Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
- DOI: 10.3350/cmh.2022.0330 [Epub ahead of print]
-
Editorials
The growing burden of non-alcoholic fatty liver disease on mortality
- Ju-Yeon Cho, Won Sohn
- DOI: 10.3350/cmh.2023.0084 [Epub ahead of print]
-
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
- Byeong Geun Song, Dong Hyun Sinn
- DOI: 10.3350/cmh.2023.0058 [Epub ahead of print]
-
Reviews
A decade of liver organoids: Advancements in disease modeling
- Yue Liu, Jian-Ying Sheng, Junjun Ding, Yun-Shen Chan
- DOI: 10.3350/cmh.2022.0428 [Epub ahead of print]
-
Original Articles
Analysis of Hepatitis C Virus Resistance-Associated Substitutions in Direct-Acting Antiviral Failure in South Korea Using Next-Generation Sequencing
- Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
- DOI: 10.3350/cmh.2022.0345 [Epub ahead of print]
-
Editorials
Editorial: Noninvasive biomarkers for liver inflammation in NAFLD: current and future
- Kee-Huat Chuah, Wah-Kheong Chan
- DOI: 10.3350/cmh.2023.0062 [Epub ahead of print]
-
The Independent Effect of Exercise on Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review
- Young-Joo Jin
- DOI: 10.3350/cmh.2023.0055 [Epub ahead of print]
-
Snapshot
Systemic therapy in advanced hepatocellular carcinoma
- Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
- DOI: 10.3350/cmh.2023.0051 [Epub ahead of print]
-
Reviews
Acute hepatitis C virus infection: clinical update and remaining challenges
- Chen-Hua Liu, Jia-Horng Kao
- DOI: 10.3350/cmh.2022.0349 [Epub ahead of print]
-
Original Articles
Taurocholic Acid Promotes Hepatic Stellate Cell Activation via S1PR2/p38 MAPK/YAP Signaling under Cholestatic Conditions
- Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun
- DOI: 10.3350/cmh.2022.0327 [Epub ahead of print]
-
Correspondance
Correspondence on Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"
- Jeong-Ju Yoo, Sang Gyune Kim
- DOI: 10.3350/cmh.2023.0044 [Epub ahead of print]
-
Reviews
Development of hepatocellular carcinoma in untreated and treated patients with chronic hepatitis B virus infection
- Chih-Lin Lin, Jia-Horng Kao
- DOI: 10.3350/cmh.2022.0342 [Epub ahead of print]
-
Editorial
Non-invasive biomarkers of liver fibrosis in NAFLD
- Basheer M, Naffaa ME, Assy N
- DOI: 10.3350/cmh.2023.0045 [Epub ahead of print]
-
Reviews
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
- Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
- DOI: 10.3350/cmh.2022.0391 [Epub ahead of print]
-
Original Articles
Factors Associated with Unrecognized Cirrhosis in Patients with Hepatocellular Carcinoma
- Yi-Te Lee, Mohammad Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
- DOI: 10.3350/cmh.2022.0450 [Epub ahead of print]
-
Reviews
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
- Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J. Tuñón, Javier González-Gallego, José L. Mauriz
- DOI: 10.3350/cmh.2022.0425 [Epub ahead of print]
-
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
- Shang-Chin Huang, Chun-Jen Liu
- DOI: 10.3350/cmh.2022.0422 [Epub ahead of print]
-
Letter to the Editor
Letter to the Editor: Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"
- Chia-Ming Chu, Yun-Fan Liaw.
- DOI: 10.3350/cmh.2023.0018 [Epub ahead of print]
-
Reviews
Clinical practice guidelines and real-life practice for hepatocellular carcinoma in Taiwan
- Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu
- DOI: 10.3350/cmh.2022.0421 [Epub ahead of print]
-
Utility of Combining PIVKA-II and AFP in the Surveillance and Monitoring of Hepatocellular Carcinoma in the Asia-Pacific Region
- Do-Young KIM, Bao Nguyen TOAN, Chee-Kiat TAN, Irsan HASAN, Lyana SETIAWAN, Ming-Lung YU, Namiki IZUMI, Nguyen Nguyen HUYEN, Pierce Kah-Hoe CHOW, Rosmawati MOHAMED, Stephen Lam CHAN, Tawesak TANWANDEE, Teng-Yu LEE, Thi Thanh Nguyen HAI, Tian YANG, Woo-Chang LEE, Henry Lik Yuen CHAN
- DOI: 10.3350/cmh.2022.0212 [Epub ahead of print]
-
The role of different viral biomarkers on the management of chronic hepatitis B For special issue ‘Challenging issues in the treatment of viral hepatitis’
- Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
- DOI: 10.3350/cmh.2022.0448 [Epub ahead of print]
-
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
- Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
- DOI: 10.3350/cmh.2022.0404 [Epub ahead of print]
-
Original Articles
The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase
- Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
- DOI: 10.3350/cmh.2022.0322 [Epub ahead of print]
-
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences, 1990-2019: a DALYs-based analysis of the Global Burden of Disease 2019 study
- Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
- DOI: 10.3350/cmh.2022.0316 [Epub ahead of print]
-
Reviews
Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective
- Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
- DOI: 10.3350/cmh.2022.0399 [Epub ahead of print]
-
Clinical practice guideline and real-life practice in hepatocellular carcinoma: Chinese perspective
- Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
- DOI: 10.3350/cmh.2022.0402 [Epub ahead of print]
-
Original Articles
Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
- Kathryn Jane Waller, Hajar Saihi, Wenhao Li, James Hallimond Brindley, Anja De Jong, Wing-kin Syn, Conrad Bessant, William Alazawi
- DOI: 10.3350/cmh.2022.0205 [Epub ahead of print]